Molecular Partners AG

MOLN · SWISS

$3.67+$0.0608 (+1.68%)TodayMarket closed ·
Prev close $3.61

Latest news

  • News

    Earnings Scheduled For May 12, 2026

  • News

    Earnings Scheduled For March 12, 2026

  • Press releaseGlobe Newswire

    Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics

  • Press releaseGlobe Newswire

    Molecular Partners to Present at 44th Annual J.P. Morgan Healthcare Conference

  • Press releaseGlobe Newswire

    Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics

  • Press releaseGlobe Newswire

    Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting

  • Press releaseGlobe Newswire

    Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action

  • Press releaseGlobe Newswire

    Molecular Partners presents additional preclinical proof-of-concept data on logic-gated CD3 Switch-DARPin at SITC 2025

  • Press releaseGlobe Newswire

    Molecular Partners to present updated data from Phase 1/2a trial of MP0533 in AML at ASH Annual Meeting

  • Press releaseGlobe Newswire

    Molecular Partners Reports Q3 2025 Financial Results and Clinical Progress, with DLL3-Targeting Radio-DARPin MP0712 Phase 1 Launch Expected in 2025

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • NewsAvi Kapoor

    EHang, Molecular Partners And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • Press releaseGlobe Newswire

    Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025

  • News

    Earnings Scheduled For August 25, 2025

  • Press releaseGlobe Newswire

    Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    Earnings Scheduled For March 6, 2025

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.